Sign In
Buy TXG
$47.27
-2.16 (-4.37%)
At Close: Jul 31, 2026
Torex Gold Provides Q3 2024 Update on Media Luna Project and Increases 2024 Production Guidance
06:00pm, Wednesday, 30'th Oct 2024
Project 87% complete; plant tie-in schedule moves to February; first copper concentrate expected in Q1 (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp.
These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results
02:41pm, Wednesday, 30'th Oct 2024
10x Genomics, Inc. TXG reported a loss for the third quarter on Tuesday.
10x Genomics, Inc. (TXG) Q3 2024 Earnings Call Transcript
08:04pm, Tuesday, 29'th Oct 2024
10x Genomics, Inc. (NASDAQ:TXG ) Q3 2024 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Cassie Corneau - Senior Director, Head of Investor Relations and Strategic Finance Se
10x Genomics (TXG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
08:01pm, Tuesday, 29'th Oct 2024
The headline numbers for 10x Genomics (TXG) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street
10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates
06:20pm, Tuesday, 29'th Oct 2024
10x Genomics (TXG) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.51 per share a year ago.
10x Genomics Reports Third Quarter 2024 Financial Results
04:05pm, Tuesday, 29'th Oct 2024
PLEASANTON, Calif. , Oct. 29, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September
Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell
05:05am, Tuesday, 29'th Oct 2024
Medical Systems, 10x Genomics and Omnicell have been highlighted in this Industry Outlook article.
Lower Instruments Sales to Hurt TXG Q3 Earnings, Prelim Sales Down
03:05pm, Monday, 28'th Oct 2024
Per a preliminary report from 10x Genomics, the company's revenues will decline for the third quarter. Lower Instruments sales are likely to have been partially offset by consumable sales growth.
3 Medical Info Systems Stocks to Gain From Healthcare Digitization
01:26pm, Monday, 28'th Oct 2024
Zacks Medical Info Systems industry stocks like Inspire Medical Systems, 10x Genomics and Omnicell are expected to gain from the GenAI wave.
10x Genomics (TXG) Upgraded to Strong Buy: Here's Why
01:01pm, Wednesday, 23'rd Oct 2024
10x Genomics (TXG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
10x Genomics (TXG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:06am, Tuesday, 22'nd Oct 2024
10x Genomics (TXG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches
04:05pm, Tuesday, 15'th Oct 2024
PLEASANTON, Calif. , Oct. 15, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products intended to de
10x Genomics: Deciphering The Preliminary Q3 Earnings
06:00am, Saturday, 12'th Oct 2024
10x Genomics has faced significant revenue declines and operational challenges, with Q3 revenue missing expectations and instrument sales dropping 46% year-over-year. Despite the setbacks, consumables
10x Genomics Crashes After 'Disruptive' Reorg Upsets Third-Quarter Sales
09:07am, Thursday, 10'th Oct 2024
10x Genomics stock crashed Thursday after the medtech reported preliminary third-quarter sales that widely missed Street expectations.
10x Genomics Announces Preliminary Select Third Quarter 2024 Results
04:05pm, Wednesday, 09'th Oct 2024
PLEASANTON, Calif. , Oct. 9, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary select results for the third quarter ended
